Abstract
A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Current Traditional Medicine
Title:Traditional Medicine - A Possible Stop Codon for COVID-19
Volume: 7 Issue: 4
Author(s): Nissar A. Reshi, Anup S. Deshpande, Namita A. Raytekar and Vasudeo P. Zambare*
Affiliation:
- Department of Life Sciences, School of Science, Sandip University, Nashik, Maharashtra,India
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Abstract: A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Export Options
About this article
Cite this article as:
Reshi A. Nissar, Deshpande S. Anup , Raytekar A. Namita and Zambare P. Vasudeo *, Traditional Medicine - A Possible Stop Codon for COVID-19, Current Traditional Medicine 2021; 7 (4) . https://dx.doi.org/10.2174/2215083806999201130103521
DOI https://dx.doi.org/10.2174/2215083806999201130103521 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Optimizing Ventilation with the Open Lung Maneuver
Current Respiratory Medicine Reviews COXIBs, CINODs and H2S-Releasing NSAIDs: Current Perspectives in the Development of Safer Non Steroidal Anti-Inflammatory Drugs
Current Medicinal Chemistry PF-04886847 (an Inhibitor of Plasma Kallikrein) Attenuates Inflammatory Mediators and Activation of Blood Coagulation in Rat Model of Lipopolysaccharide (LPS) - Induced Sepsis
Cardiovascular & Hematological Agents in Medicinal Chemistry Can Saffron (Crocus sativus) be Effective in the Treatment of Leishmaniasis?
Infectious Disorders - Drug Targets STAT1 as a New Molecular Target of Anti-Inflammatory Treatment
Current Medicinal Chemistry Patent Selections
Recent Patents on Drug Delivery & Formulation Tannic Acid Exhibits Adjuvant Activity by Enhancing Humoral and Cell-Mediated Immunity Against BSA as a Protein Antigen
Protein & Peptide Letters The NMDA Receptor NR2B Subunit: A Valid Therapeutic Target for Multiple CNS Pathologies
Current Medicinal Chemistry Placental Cytokines in the Pathogenesis of Preeclampsia and Hellp Syndrome
Current Women`s Health Reviews NF-κB Signaling and Carcinogenesis
Current Pharmaceutical Design Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences
Endocrine, Metabolic & Immune Disorders - Drug Targets Lessons from Viruses: Controlling the Function of Transmembrane Proteins by Interfering Transmembrane Helices
Current Medicinal Chemistry Anticancer Actions of Omega-3 Fatty Acids - Current State and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry subject Index To Volume 1
Current Medicinal Chemistry Exploiting Molecular Virulence Determinants in Burkholderia to Develop Vaccine Antigens
Current Medicinal Chemistry Herbal Resources to Combat a Progressive & Degenerative Nervous System Disorder- Parkinson’s Disease
Current Drug Targets Placebo Preparation for the Proper Clinical Trial of Herbal Medicine - Requirements, Verification and Quality Control
Recent Patents on Inflammation & Allergy Drug Discovery Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets Analgesic Prodrugs for Combating their Side-Effects: Rational Approach
Current Drug Delivery Molecular Farming of Pharmaceutical Proteins Using Plant Suspension Cell and Tissue Cultures
Current Pharmaceutical Design